Professor Wood provides interesting data on the effect of the nature of the blood sample on the measured levels of lactoferrin and elastase-a-Pl. In my study I measured plasma lactoferrin in both venous and capillary blood from adult volunteers. These specimens were processed in similar ways to those taken from the infants in the study. As I reported, there was no significant difference between these groups which suggested that PMN activation was not contributing to the levels that I was measuring. The plasma lactoferrin levels found in term babies at 15 weeks were again not significantly different from those found in adults. The former were, however, capillary samples taken in the same way as those at 7 and II weeks, which were significantly higher.
Such PMN activation might lead to a scattered elevation in lactoferrin concentrations. However, in the preterm infants who were less ill and had capillary sampling because of the absence of venous catheters, etc., the measured plasma lactoferrin levels were consistent from day to day. In conclusion, whilst I find Professor Wood's data
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interesting, and will examine our sampling techniques even more critically in the future, I do not beleive that this is the explanation for the marked increases I found in infants demonstrating clinical signs of infection. 
PHSCOIT

QUALITY CONTROL IN URINARY GLYCOSAMINOGLYCAN SCREENING
We were interested to read the article by Brimble et al,' on quality control in urinary glycosaminoglycan screening. Mrs Brimble was kind enough to supply us with samples of urine from patients with mucopolysaccharidoses to assist us in evaluating our screening method. As a result of this exercise, we became aware of an error in our method which may have become widespread. We use the quantitative CPC screening test, as described in the appendix to a review on laboratory methods and the diagnosis of mucopolysaccharidoses. This publication' contained an error in the calculation which leads to a tenfold underestimation of the glycosaminoglycan concentration. The error was corrected in a subsequent publication,' but has been perpetuated in at least one standard textbook of clinical chemistry." (We also note, incidentally, that reference 3 contains a new error; page 4 and table 3 include mention of CPC units and mmol hexuronic acid per mol creatinine.)
Of course, we should ourselves have spotted the error, but we did not, and we would like to take the opportunity to warn others who may be setting up this method.
M PHILIP BAILEY BERNARD FRoCKS
Biochemistry Department, Royal Sussex County Hospital, Eastern Road, Brighton BN2 5BE, UK
